Tag Archives: chronic condition

Elevance Health Agrees to Acquire Paragon Healthcare

Elevance Health entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies

Elevance Health to Acquire BioPlus Specialty Pharmacy

Elevance Health (Elevance) announced that it has entered into an agreement with CarepathRx, a portfolio company of Nautic Partners, to acquire BioPlus, a comprehensive specialty pharmacy

AllianceRx Walgreens Prime Rebranding as AllianceRx Walgreens Pharmacy

AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand

Thirty Madison and Nurx Agree to Merge under the Thirty Madison Brand

Thirty Madison and Nurx, the leader in female-focused digital healthcare, recently entered into a definitive agreement to merge under the Thirty Madison brand

Recent Activities Position AscellaHealth As a Leader in Specialty Pharmaceutical Services

AscellaHealth recently announced a comprehensive suite of Specialty Pharmacy (SP) services, including pre-commercialization, outsourced market access, wholesale, 3PL, limited distribution drug (LDD) fulfillment, and custom Patient Support and HUB Services

GuideWell and Triple-S Management Plan to Combine

GuideWell and Triple-S Management Corporation, a leading health care services company in Puerto Rico, announced they will combine to transform the health care experience for their members in Florida and Puerto Rico

Shields Acquires Excelera Shining Spotlight on Health System Specialty Pharmacies

Since 2015, the prevalence of health system-owned specialty pharmacies in large hospitals has doubled, with nearly 90 percent of large hospitals operating a specialty pharmacy in 2019

Does UPMC’s Divestiture of Chartwell Pennsylvania Signal a New Trend?

CarepathRx recently announced that it plans to acquire part of the University of Pittsburgh Medical Center’s (UPMC’s) Chartwell pharmacy subsidiary in a $400 million deal.